Frederick G. Vogt, Interim CEO & General Counsel at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 25,000 shares at $1.69 ($42K) on 2025-05-14, disclosed to the SEC on 2025-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |